<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Yourgene set to hit ambitious growth target in half year update	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 02 Dec 2019 12:56:18 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: Yourgene shares rise on confident board expectations - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/#comment-12930</link>

		<dc:creator><![CDATA[Yourgene shares rise on confident board expectations - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 02 Dec 2019 12:56:18 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22631#comment-12930</guid>

					<description><![CDATA[[&#8230;] October, Yourgene looked set to hit an ambitious growth target in their half year update, which caused shares to [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] October, Yourgene looked set to hit an ambitious growth target in their half year update, which caused shares to [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Pfizer smash market and analyst estimates - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/#comment-12316</link>

		<dc:creator><![CDATA[Pfizer smash market and analyst estimates - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 29 Oct 2019 12:35:37 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22631#comment-12316</guid>

					<description><![CDATA[[&#8230;] TRX) shares have fallen after warnings of lower revenues, Yourgene Health Plc (LON:YGEN) have hit their ambitious growth target, and Salarius Ltd (NASDAQ: SLRX) have secured a new patent for [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] TRX) shares have fallen after warnings of lower revenues, Yourgene Health Plc (LON:YGEN) have hit their ambitious growth target, and Salarius Ltd (NASDAQ: SLRX) have secured a new patent for [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Warnings of lower revenues drive Tissue Regenix stocks down - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/#comment-12233</link>

		<dc:creator><![CDATA[Warnings of lower revenues drive Tissue Regenix stocks down - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 22 Oct 2019 15:01:00 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22631#comment-12233</guid>

					<description><![CDATA[[&#8230;] been flexible in Pharmaceuticals and health, seen with to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] been flexible in Pharmaceuticals and health, seen with to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Itaconix set to miss market forecasts causing stock dip - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/#comment-12228</link>

		<dc:creator><![CDATA[Itaconix set to miss market forecasts causing stock dip - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 22 Oct 2019 14:50:12 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22631#comment-12228</guid>

					<description><![CDATA[[&#8230;] other firms in the industry catch up such as  Yourgene Health PLC (LON: YGEN) and Salarius Pharmaceuticals Inc (NASDAQ: SLRX) Itaconix have to ensure that this [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] other firms in the industry catch up such as  Yourgene Health PLC (LON: YGEN) and Salarius Pharmaceuticals Inc (NASDAQ: SLRX) Itaconix have to ensure that this [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Collagen Solutions sees consistent periods of revenue growth - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/yourgene-set-to-hit-growth-target-in-half-year-update/#comment-12201</link>

		<dc:creator><![CDATA[Collagen Solutions sees consistent periods of revenue growth - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 22 Oct 2019 11:35:54 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22631#comment-12201</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) and Tissue Regenix Group PLC (LON: [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) and Tissue Regenix Group PLC (LON: [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
